Harry Glorikian Email & Phone Number

New York, Ny, Us

The Scientia Ventures team is a group of co-founders, entrepreneurial operators, and investors whose members have collaborated on various projects together in the healthcare industry.We have repeatedly created, invested in, and exited multiple companies in therapeutics, precision medicine, diagnostics, and various high impact technology verticals.Through our deep domain expertise and insight, we are able to translate transformational science into successful business ventures. Our experience allows us to create companies around acquired IP or invest in traditional early stage companies.

AI Solutions Delivering Tomorrow's Knowledge TodayWe have built scalable and explainable AI solutions to deliver mission critical insights by uncovering hidden relationships in data.

The power of data is remaking everything in healthcare—not just the way doctors diagnose patients, but the way pharma companies develop drugs and the way hospitals and insurers control costs and create value. Here at The Harry Glorikian Show, host Harry Glorikian talks with the executives, entrepreneurs, physicians, and scientists who are pushing that high-tech revolution forward. Harry's 2017 book "MoneyBall Medicine" offered an inside look at the ways genomics, machine learning, and other trends are improving healthcare delivery and efficiency. In his subsequent book published in 2021 - The Future You, How Artificial Intelligence Can Help You Get Healthier, Stress Less and Live Longer explores how AI is disrupting healthcare and what everyone needs to know to navigate the new medical paradigm and improve your own personal health.

Senior Executive | Board Director | Investor – Life Sciences | Biotech | Big Data | Healthcare | Digital Health | Author

Boston, Ma, Us

The Bioengineering Industrial Advisory Board unites a diverse group of bright and enterprising leaders from across the sector to create a strong resource pool for students, faculty, and administrators, as the department continues to grow and thrive.

Boston, Ma, Us

Member of Industry Advisory CommitteeMusculoskeletal Translational Innovation InitiativeCarl J Shapiro Department of Orthopaedic SurgeryBeth Israel Deaconess Medical Center

Richmond Hill, Ontario, Ca

Independent Board DirectorDirector, Chairman of Compensation & Human Resources Committee Member of Strategy Committee

Mechelen, Be

New York, Ny, Us

Drawbridge Health – Making Sampling SimplerDrawbridge Health is a medical technology company fusing the science of chemistry with the fundamentals of logistics to access and immediately stabilize the blood sampling process, anywhere. Their mission is to power the shift in healthcare from being reactive to proactive, enabling predictive medicine to be realized by bridging diagnostic testing from sample to delivery to decision. This transformation begins with how they approach the collection and interpretation of medical diagnostic tests—the data that they use to make nearly all of medical decisions. The current sample collection and testing paradigm is not only inconvenient and costly for consumers and medical providers alike, but is incomplete and not tailored to the individual. Drawbridge Health is building a new sample acquisition and stabilization platform to enable the broad access, accurate, and actionable information necessary to pave the way for truly individualized and predictive healthcare.

San Mateo, California, Us

Evidation Health Advisory Board Member - Assisted in the planning of the company and continue to assist in the long term strategy and plan for growth. Evidation Health seeks to improve health outcomes through clinically and economically beneficial digital health solutions and new approaches to predictive analytics.

San Diego, California, Us

Nucelis was merged into CibusNucelis delivers high-value, performance-focused and sustainably-sourced ingredient solutions to the personal care, nutrition and flavor and fragrance markets. This is accomplished by leveraging their proprietary, non-transgenic gene editing technologies and integrated production development platform.

Sunnyvale, Ca, Us

Advisory Board Member - Helping develop the long-term strategy and plan for growth

Chicago, Us

Entrepreneur in Residence - co-founding newcos from the ground up - ideation, identifying the market opportunity, developing the offering concept, coordinating the market analysis, development of the business and operating plans, asset/IP understanding, financing, hiring and partnering strategies

Cambridge, Ma, Us

Advisory Board Member - helping develop Draper’s long-term strategy and plan for growing the biomedical business area.

Bethesda, Md, Us

Bethesda, Md, Us

* Brought on board to provide vision, leadership, and a vast network of strategic global relationships to create a world-class life sciences service provider organization for innovators in next-generation medical products.

Cambridge, Ma, Us

Scientia Advisors is an international strategy & management consulting firm with a concentration in life sciences & healthcare.Co-Founder & Managing Partner* Built the organization from the ground up. All operational aspects - HR, Marketing, Etc. * Provided entrepreneurial vision and expertise in creating and growing a financially vibrant and operationally sound organization of consulting professionals. * Built solid international reputation as a go-to firm for strategic advice in healthcare and life sciences.* Expanded service offerings to operations implementation, pricing, and nation-based expansion on a global scale.* Established ScientiaNET, the global network of nearly 135,000 science and business opinion leaders and SMEs. * Continued to grow client portfolio, revenue, headcount, and profitability in spite of economic recession.

Waltham, Ma, Us

* Executed a number of different roles – including Product Manager for Immunoassay Technologies, Product Manager for DNA Synthesis, and Senior Manager, Global Business Development – as the company experienced phenomenal growth, serial reorganization, and scientific innovation.* Played key roles in genomics and proteomics; within 4 years, division revenues more than doubled to $1.6 billion.* Frequently called on to plan and manage special projects based on reputation for aggressively pushing forward the decision-making process of C-suite management for high-impact results.* Conceived, developed the strategy, and gained executive approval for $32.8M acquisition of Boston Probes, opening the door for new opportunities in peptide nucleic acid probe technology.

* Recruited to kick-start a stagnant sales presence and marketing process.* Built sales force from the ground up; established IT network and CRM software; rebuilt R&D function; reformulated key product line.* Developed and taught immunohistochemistry (IHC) process courses to researchers, physicians, and technicians.

* Built X-Cell from ground up to significant revenue run rate and created the formulation for novel IHS reagent set, favorable positioning the company for quick acquisition.

* Excelled in first sales role as top performer every year.* Doubled sales in 3 territories in less than 3 years.* Proactively developed and taught 60-80 CEU-approved courses on immunohistochemistry (a new area in pathology labs) to technologists and pathologists.* Gained reputation as sought after IHC SME speaker.

Mba

Ba, Biology